Definitions
Sorry, no definitions found. Check out and contribute to the discussion of this word!
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word rilonacept.
Examples
-
Arcalyst, also known as rilonacept or IL-1 Trap, was approved in February as a treatment for a group of extremely rare inflammatory diseases called cryopirin-associated periodic syndromes, which can cause fevers, chills and joint pain.
-
In addition to ARCALYST® (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in Phase 3 clinical trials for the potential treatment of gout, diseases of the eye (wet age-related macular degeneration, central retinal vein occlusion, and diabetic macular edema), and certain cancers.
unknown title 2011
-
ARCALYST® (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, inflammatory diseases, and pain, and has preclinical programs in other diseases and disorders.
-
ARCALYST (rilonacept) Injection for subcutaneous use for the treatment of a rare, inherited, inflammatory condition.
-
ARCALYST® (rilonacept) Injection for Subcutaneous Use, its first commercialized product,
-
ARCALYST® (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, inflammatory diseases, and pain, and has preclinical programs in other diseases and disorders.
-
ARCALYST (rilonacept) Injection for subcutaneous use for the treatment of a rare, inherited, inflammatory condition.
-
ARCALYST® (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, inflammatory diseases, and pain, and has preclinical programs in other diseases and disorders.
-
In addition to ARCALYST® (rilonacept) Injection for Subcutaneous Use, its first commercialized product,
Medindia Health News 2010
-
ARCALYST® (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, inflammatory diseases, and pain, and has preclinical programs in other diseases and disorders.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.